Início › Câncer de Pâncreas › Virgínia › Arlington
Ensaios clínicos de Câncer de Pâncreas em Arlington, VA
33 estudos para Câncer de Pâncreas estão buscando participantes em locais em Arlington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- Inova Fair Oaks Hospital, Fairfax · a 11 mi de distância
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RecrutandoFase 3
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study of PHN-012 in Patients With Advanced Solid Tumors
RecrutandoFase 1
- PHN-012-001 Site, Fairfax · a 11 mi de distância
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecrutandoFase 1
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RecrutandoFase 3
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RecrutandoFase 3
- Investigative Site US057, Fairfax · a 11 mi de distância
- Investigative Site US065, Fairfax · a 11 mi de distância
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RecrutandoFase 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · a 11 mi de distância
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecrutandoFase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · a 11 mi de distância
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RecrutandoFase 1
- NEXT - Virginia, Fairfax · a 11 mi de distância
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Oncology, Fairfax · a 11 mi de distância
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RecrutandoEstudo observacional
- Inova Fairfax Hospital, Falls Church · a 4 mi de distância
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- Inova Fair Oaks Hospital, Fairfax · a 11 mi de distância
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RecrutandoFase 2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RecrutandoFase 1
- Virginia Cancer Specialists, PC, Fairfax · a 11 mi de distância
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RecrutandoFase 3
- Inova Fairfax Hospital, Falls Church · a 4 mi de distância
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- Inova Fair Oaks Hospital, Fairfax · a 11 mi de distância
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
Pancreatic Cancer Early Detection Consortium
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecrutandoFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · a 11 mi de distância
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RecrutandoFase 1
- Research Site, Fairfax · a 11 mi de distância
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RecrutandoFase 3
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- Inova Fair Oaks Hospital, Fairfax · a 11 mi de distância
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Next Oncology Virginia, Fairfax · a 11 mi de distância
A 2-part Phase 1/2 Open-label Trial on ODM-212
RecrutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RecrutandoFase 1/2
- NEXT, Virginia, Fairfax · a 11 mi de distância
Ensaios de Câncer de Pâncreas em outras cidades
- Houston, TX61 estudos
- New York City, NY60 estudos
- Boston, MA43 estudos
- Nashville, TN39 estudos
- Los Angeles, CA35 estudos
- St. Louis, MO33 estudos
- Baltimore, MD31 estudos
- San Antonio, TX31 estudos
- Philadelphia, PA26 estudos
- Tampa, FL26 estudos
- Durham, NC24 estudos
- San Diego, CA24 estudos
Outros estudos em Arlington
- Câncer de Pulmão de Não Pequenas Células104 estudos
- Câncer Metastático53 estudos
- Câncer Colorretal52 estudos
- Câncer (todos os tipos)48 estudos
- Câncer de Mama47 estudos
- Câncer de Ovário46 estudos
- Câncer de Pulmão41 estudos
- Câncer Endometrial39 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço26 estudos
- Câncer de Pulmão de Células Pequenas23 estudos
- Câncer de Estômago20 estudos
- Câncer de Mama Triplo-Negativo20 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.